Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:cmc13

Total Results:

268


Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment

Marsch, Lisa A; Guarino, Honoria; Acosta, Michelle; Aponte-Melendez, Yesenia; Cleland, Charles; Grabinski, Michael; Brady, Ronald; Edwards, Joyce
This study is the first experimental trial to evaluate the effectiveness of a Web-based behavioral intervention when deployed in a model where it partially substituted for standard counseling in a community-based specialty addiction treatment program. New opioid-dependent intakes in methadone maintenance treatment (n=160) were randomly assigned for 12months to either: (1) standard treatment or (2) reduced standard treatment plus a Web-based psychosocial intervention, the Therapeutic Education System (TES). Results demonstrated that replacing a portion of standard treatment with TES resulted in significantly greater rates of objectively measured opioid abstinence (48% vs. 37% abstinence across all study weeks; F(1, 158)=5.90, p<.05 and 59% vs. 43% abstinence on weeks participants provided urine samples for testing; F(1, 158)=8.81, p<.01). This result was robust and was evident despite how opioid abstinence was operationally defined and evaluated. The potential implications for service delivery models within substance abuse treatment programs and other healthcare entities are discussed.
PMCID:3839618
PMID: 24060350
ISSN: 0740-5472
CID: 627682

HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts

Gwadz, Marya; Applegate, Elizabeth; Cleland, Charles; Leonard, Noelle Regina; Wolfe, Hannah; Salomon, Nadim; Belkin, Mindy; Riedel, Marion; Banfield, Angela; Sanfilippo, Lisa; Wagner, Andrea; Mildvan, Donna
A substantial proportion of persons living with HIV/AIDS (PLHA) delay, decline, or discontinue antiretroviral therapy (ART) when it is medically indicated (40-45%), largely African-Americans and Latinos/Hispanics. This study explores the feasibility of locating PLHA, who are not on ART (PLHA-NOA) through clinics and peer-referral; compares the two cohorts on multi-level barriers to ART; and examines readiness to initiate/reinitiate ART, a predictor of treatment outcomes. We recruited adult HIV-infected African-American and Latino/Hispanic PLHA-NOA through HIV hospital clinics and peer-referral in 2012-2013. Participants were engaged in structured 1-h assessments with reliable/valid measures on barriers to ART. We found that recruitment through peers (63.2%, 60/95) was more feasible than in clinics (36.8%, 35/90). Participants were 48.0 years old and had lived with HIV for 14.7 years on average, and 56.8% had taken ART previously. Most (61.1%) were male and African-American (76.8%), and 23.2% were Latino/Hispanic. Peer-recruited participants were older, had lived with HIV longer, were less engaged in HIV care, and were more likely to have taken ART previously. The cohorts differed in reasons for discontinuing ART. Levels of ART knowledge were comparable between cohorts (68.5% correct), and there were no differences in attitudes toward ART (e.g., mistrust), which were in the neutral range. In bivariate linear regression, readiness for ART was negatively associated with physician mistrust (B = -10.4) and positively associated with self-efficacy (B = 5.5), positive outcome expectancies (B = 6.3), beliefs about personal necessity of ART (B = 17.5), and positive internal norms (B = 7.9). This study demonstrates the feasibility of engaging this vulnerable population through peer-referral. Peer-recruited PLHA evidence particularly high rates of risk factors compared to those in hospital clinics. Interventions to support ART initiation and continuation are sorely needed for both subgroups.
PMCID:4100062
PMID: 25077137
ISSN: 2296-2565
CID: 1090222

L-Dex ratio in detecting and diagnosing breast cancer-related lymphedema: Reliability, sensitivity, and specificity. [Meeting Abstract]

Fu, Mei R; Cleland, Charles M; Guth, Amber Azniv; Kayal, Maia; Haber, Judith; Cartwright, Francis; Kleinman, Robin; Kang, Yang; Scagliola, Joan; Axelrod, Deborah M
ISI:000335564700007
ISSN: 1527-7755
CID: 1028902

The Korean version of the Symptom Experience Index: A psychometric study

Ryu, Eunjung; Kim, Kyunghee; Choi, So Young; Cleland, Charles M; Fu, Mei R
BACKGROUND: Symptom assessment and management are vital aspects of patient care through the entire illness trajectory. Patients often experience two or more symptoms concurrently. Building global assessment capacity on symptoms holds significant promise for advancing the science of nursing. The Symptom Experience Index is a reliable and valid patient-centered health outcome measure developed in the United States to assess multiple symptoms and distress. No Korean version is available for Korean healthcare professionals and patients to promote an accurate assessment of multiple symptoms. OBJECTIVE: To translate the Symptom Experience Index into Korean language and assess its psychometric properties in Korean patients and healthy adults. DESIGN: A psychometric study with a cross-sectional design. SETTING: Two hospitals and a large university in Seoul, Korea in 2009. PARTICIPANTS: A purposive sample of 230 adult participants, including medical-surgical and oncology patients, as well as healthy university students. METHODS: The English Symptom Experience Index was translated to Korean language using an integrative translation method to ensure its semantic equivalence and content validity. The Korean version was then pretested and tested using a contrast-group and test-retest method. RESULTS: Semantically, no modifications to items were needed in terms of comparability of language and similarity of interpretability. Feedback on the pretest of the Korean version by 15 Korean adult patients resulted in one item deletion and one item modification. The Korean version demonstrated high internal consistency with the Cronbach's alpha coefficient: total symptom experience of 0.92, occurrence of 0.91 and distress of 0.90. Intra-class correlation coefficients demonstrated strong stability over time: total symptom experience (ICC=0.82; 95% CI=0.73-0.88), occurrence (ICC=0.77; 95% CI=0.66-0.84), and distress (ICC=0.85; 95% CI=0.77-0.89). Construct validity was supported by (1) factor analysis; (2) differences in symptom experience scores between healthy university students and patient groups; and (3) positive correlations between symptom experience scores and functional impairment. CONCLUSIONS: Our study provided evidence to support psychometric properties of the Korean Symptom Experience Index. The use of the instrument can help patients who speak Korean language systematically report symptoms and assist healthcare professionals in assessing multiple symptom experience.
PMID: 23290258
ISSN: 0020-7489
CID: 427012

Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials

Leonard, N R; Banfield, A; Riedel, M; Ritchie, A S; Mildvan, D; Arredondo, G; Cleland, C M; Gwadz, M V
AIDS clinical trials (ACTs) are critical to the development of new treatments for HIV infection. However, people of color living with HIV/AIDS are involved in ACTs at disproportionally low rates, with African-Americans experiencing the greatest under-representation. In this article, we describe the core elements and key characteristics of a highly efficacious multi-component peer-driven intervention (PDI) designed to increase rates of screening for and enrollment into ACTs among African-American and Latino/Hispanic individuals, by addressing the main complex, multi-level barriers they experience to ACTs. We discuss the process of developing the intervention, the theoretical models guiding its delivery format and content, and provide an overview of the intervention's components. We then use brief case studies to illustrate a number of key issues that may arise during intervention implementation. Finally, we describe lessons learned and provide recommendations for the PDI's uptake in clinical and clinical trials settings.
PMCID:3708137
PMID: 23669214
ISSN: 0268-1153
CID: 464772

ESTIMATING THE IMPACT OF COMBINED PREVENTION INTERVENTIONS TARGETING 15-24 YEARS-OLD MEN AND WOMEN IN NYANZA, KENYA [Meeting Abstract]

Alsallaq, R; Buttolph, J; Cleland, C; Hallett, T; Kurth, A
ISI:000209506600229
ISSN: 1472-3263
CID: 2734052

Sexually transmitted infection risk perception among female college students

Hickey, Mary T; Cleland, Chuck
PURPOSE: To describe perceived risk for sexually transmitted infections (STIs) and sexual risk behavior among sexually active female college students. DATA SOURCES: An online, anonymous survey was used to collect data from 458 sexually active female students between the ages of 18-24 enrolled at a private, suburban university in the mid-Atlantic region. CONCLUSION: Most women in this study did not consider themselves at risk for contracting an STI, despite low levels of condom use. Perceiving no risk and never using condoms were both more common among women with just one sex partner. Further investigation of factors contributing to individual risk perception is warranted in order to develop effective prevention programs. IMPLICATIONS FOR PRACTICE: Nurses and advanced practice nurses who work with women, particularly at-risk women, should be aware of low levels of risk perception for STIs, despite engaging in risk-taking behaviors. Education regarding strategies to reduce and prevent contracting STIs should be incorporated into encounters with women seeking health care, and in health promotion settings.
PMID: 24170621
ISSN: 2327-6886
CID: 816452

The Experience of Screening for HIV/AIDS Medical Studies among African-American/Black and Latino/Hispanic Persons Living with HIV/AIDS: A Mixed-Methods Exploration

Engel, Stephanie; Gwadz, Marya Viorst; Cleland, Charles M
OBJECTIVE: African-American/Black and Latino/Hispanic persons living with HIV/AIDS (i.e., "PLHA of color") are under-represented in HIV/AIDS medical studies (HAMS). A crucial entry point into HAMS is screening, but PLHA of color face serious barriers to screening compared to Whites. Recently we evaluated a social/behavioral intervention that substantially increased rates of HAMS screening among PLHA of color. Yet very little is known about the actual screening experience for these under-represented subgroups. Thus, the objectives of the present study were to explore participants' motivations for and experiences of HAMS screening. METHODS: A total of 186 participants in the larger study's intervention arm were screened for HAMS, 35 of whom also participated in qualitative interviews. Participants engaged in a structured interview about the screening experience at 4- and 12- months post-baseline (14 items, Cronbach's alpha=0.72). Further, from a qualitative data set we purposively selected a set of three case studies to contextualize and enrich quantitative findings on screening experiences. RESULTS: The screening experience was overwhelmingly positive. Almost all participants reported being treated with dignity and respect, did not feel they were being treated like a "guinea pig," and experienced a high level of trust in the setting and the screener, with no gender or racial/ethnic differences, and no differences based on whether participants were found eligible for HAMS during screening. A number of areas where screening could be improved were also identified. CONCLUSIONS: Despite the complex barriers PLHA of color experience to screening for HAMS, the experience of screening was positive. Moreover, HAMS screening experiences were positive regardless of gender, race/ethnicity, or HAMS eligibility. HAMS screening can therefore be a productive learning experience that may reduce patient concerns about participating in HAMS. As such, fostering screening among PLHA of color can be an important component of reducing racial/ethnic disparities in HAMS.
PMCID:4443749
PMID: 26023355
ISSN: 2155-6113
CID: 1603782

L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity

Fu, M R; Cleland, C M; Guth, A A; Kayal, M; Haber, J; Cartwright, F; Kleinman, R; Kang, Y; Scagliola, J; Axelrod, D
Advances in bioelectrical impedance analysis (BIA) permit the assessment of lymphedema by directly measuring lymph fluid changes. The objective of the study was to examine the reliability, sensitivity, and specificity of cross-sectional assessment of BIA in detecting lymphedema in a large metropolitan clinical setting. BIA was used to measure lymph fluid changes. Limb volume by sequential circumferential tape measurement was used to validate the presence of lymphedema. Data were collected from 250 women, including healthy female adults, breast cancer survivors with lymphedema, and those at risk for lymphedema. Reliability, sensitivity, specificity and area under the ROC curve were estimated. BIA ratio, as indicated by L-Dex ratio, was highly reliable among healthy women (ICC=0.99; 95% CI = 0.99 - 0.99), survivors at-risk for lymphedema (ICC=0.99; 95% CI = 0.99 - 0.99), and all women (ICC=0.85; 95% CI = 0.81 - 0.87); reliability was acceptable for survivors with lymphedema (ICC=0.69; 95% CI = 0.54 to 0.80). The L-Dex ratio with a diagnostic cutoff of >+7.1 discriminated between at-risk breast cancer survivors and those with lymphedema with 80% sensitivity and 90% specificity (AUC=0.86). BIA ratio was significantly correlated with limb volume by sequential circumferential tape measurement. Cross-sectional assessment of BIA may have a role in clinical practice by adding confidence in detecting lymphedema. It is important to note that using a cutoff of L-Dex ratio >+7.1 still misses 20% of true lymphedema cases, it is important for clinicians to integrate other assessment methods (such as self-report, clinical observation, or perometry) to ensure the accurate detection of lymphedema.
PMCID:4040962
PMID: 24354107
ISSN: 0024-7766
CID: 790542

Evaluating Alcoholics Anonymous's effect on drinking in Project MATCH using cross-lagged regression panel analysis

Magura, Stephen; Cleland, Charles M; Tonigan, J Scott
OBJECTIVE: The objective of the study is to determine whether Alcoholics Anonymous (AA) participation leads to reduced drinking and problems related to drinking within Project MATCH (Matching Alcoholism Treatments to Client Heterogeneity), an existing national alcoholism treatment data set. METHOD: The method used is structural equation modeling of panel data with cross-lagged partial regression coefficients. The main advantage of this technique for the analysis of AA outcomes is that potential reciprocal causation between AA participation and drinking behavior can be explicitly modeled through the specification of finite causal lags. RESULTS: For the outpatient subsample (n = 952), the results strongly support the hypothesis that AA attendance leads to increases in alcohol abstinence and reduces drinking/ problems, whereas a causal effect in the reverse direction is unsupported. For the aftercare subsample (n = 774), the results are not as clear but also suggest that AA attendance leads to better outcomes. CONCLUSIONS: Although randomized controlled trials are the surest means of establishing causal relations between interventions and outcomes, such trials are rare in AA research for practical reasons. The current study successfully exploited the multiple data waves in Project MATCH to examine evidence of causality between AA participation and drinking outcomes. The study obtained unique statistical results supporting the effectiveness of AA primarily in the context of primary outpatient treatment for alcoholism.
PMCID:3602358
PMID: 23490566
ISSN: 1937-1888
CID: 427002